Primary Record
alpha-GalCer
- In stock
- 2,482 g
- Purity
- 99.6 %
- CAS
- 158021-47-7
Compound Identifiers & Properties
- CAS
- 158021-47-7
- PubChem CID
- 2826713
- SMILES
- CCCCCCCCCCCCCCCCCCCCCCCCCC(=O)N[C@@H](CO[C@@H]1[C@@H]([C@H]([C@H]([C@H](O1)CO)O)O)O)[C@@H]([C@@H](CCCCCCCCCCCCCC)O)O
- Canonical SMILES
- CCCCCCCCCCCCCCCCCCCCCCCCCC(=O)N[C@@H](CO[C@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O)[C@H](O)[C@H](O)CCCCCCCCCCCCCC
Names & Synonyms
- alpha-GalCer
- KRN7000
- alpha-Galactosylceramide
- Krn 7000
- .alpha.-galcer
- 158021-47-7
- Krn-7000
- -Galactosylceramide
- a-Gal-Cer
- |A-Galactosylceramide
- a-GalCer
- |A-GalCer
- alpha-Galactosyl Ceramide
- ??-Galactosylceramide
- alpha-GC(C26)
- |A-Galactosyl Ceramide
- Alpha Galactosylceramide
- alpha-GC (C26)
- -GalCer;KRN7000
- ?-GALCER
- AC1MCVU8
- RefChem:794363
- CCRIS 8968
- A-GALACTOSYLCERAMIDE
- Epitope ID:130694
- Epitope ID:738312
- UNII-WX671898JF
- DTXSID40935847
- CHEBI:466659
- alpha-Galacturonosyl ceramide
- WX671898JF
- RCAI-56
- C50H99NO9
- RGI-7000
- SCHEMBL512949
- AGL-582
- CHEBI:132148
- Galalpha-Cer(t18:0/26:0)
- MFCD00939559
- VQFKFAKEUMHBLV-BYSUZVQFSA-N
- CHEMBL384200
- orb1707685
- RGI-2001
- alpha-GalCer(t18:0/26:0)
- CHEMID158021477
- DTXCID601766457
- GLXC-20229
- GLXC-26234
- EX-A5755
- C50-H99-N-O9
- ZINC87496076
- AKOS040741093
- CID2826713
- DB12232
- MG15978
- CID:2826713
- AC-31508
- DA-49185
- SID:53788911
- SID:53789946
- J671.943K
- NS00073040
- 1-O-(alpha-D-galactosyl)-N-hexacosanoylphytosphingosine
- C16892
- 1-O-(alpha-D-galactopyranosyl)-N-hexacosanoylphytosphingosine
- alpha-Galactosylceramide(a-Gal-Cer) (synthetic)
- C103873
- C493154
- A1013243
- |A-Galactosyl Ceramide Supplier: Funakoshi Co. Ltd.
- 1-O-(|A-D-galactosyl)-N-hexacosanoylphytosphingosine
- Q27105159
- N-((2S,3S,4R)-3,4-dihydroxy-1-(((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)octadecan-2-yl)hexacosanamide
- 1-O-alpha-D-Galactopyranosyl-N-hexacosanoylphytosphingosine
- B1370-001131
- KRN 7000, 1S-(1R*,2R*,3S*)-beta-D-galacto isomer
- N-[(2S,3S,4R)-1-(alpha-D-galactopyranosyloxy)-3,4-dihydroxyoctadecan-2-yl]hexacosanamide
- N-[(2S,3S,4R)-3,4-dihydroxy-1-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoctadecan-2-yl]hexacosanamide
- N-{(1S,2R,3S)-1-[(ALPHA-D-GALACTOPYRANOSYLOXY)METHYL]-2,3-DIHYDROXYHEPTADECYL}HEXACOSANAMIDE
- (2S,3S,4R)-1-O-(alpha-D-galactosyl)-N-hexacosanoyl-2-amino-1,3,4-octadecanetriol
- (4R)-1-O-alpha-D-Galactopyranosyl-N-hexacosanoyl-4-hydroxysphinganine
- AgH
- (2S,3S,4R)-1-(alpha-D-Galactopyranosyloxy)-2-(1-oxohexacosylamino)octadecane-3,4-diol
- (2S,3S,4R)-1-(alpha-D-Galactopyranosyloxy)-2-(hexacosanoylamino)-3,4-octadecanediol
- (2S,3S,4R)-1-(alpha-D-Galactopyranosyloxy)-2-(hexacosanoylamino)octadecane-3,4-diol
- (2S,3S,4R)-1-O-(|A-D-Galactosyl)-N-hexacosanoyl-2-amino-1,3,4-octadecanetriol
- [(2S,3S,4R)-2-(1-Oxohexacosylamino)-3,4-dihydroxyoctadecyl]alpha-D-galactopyranoside
- N-[(1S,2S,3R)-1-(alpha-D-Galactopyranosyloxymethyl)-2,3-dihydroxyheptadecyl]hexacosanamide
- N-[(1S,2S,3R)-1-[(|A-D-Galactopyranosyloxy)methyl]-2,3-dihydroxyheptadecyl]hexacosanamide
- N-[(1S,2S,3R)-1-[(a-D-Galactopyranosyloxy)methyl]-2,3-dihydroxyheptadecyl]hexacosanamide
- N-[(2S,3S,4R)-1-(alpha-D-Galactopyranosyloxy)-3,4-dihydroxyoctadecane-2-yl]hexacosaneamide
- (2S,3S,4R)-1-O-(alpha-D-Galactosyl)-N-hexacosanoyl-2-amino-1,3,4-octadecanetriol, >=95% (TLC)
- 973-258-3
- a-Gal-Cer<br/>N-[(1S,2S,3R)-1-[(a-D-Galactopyranosyloxy)methyl]-2,3-dihydroxyheptadecyl]hexacosanamide<br/>KRN7000
- HEXACOSANAMIDE, N-((1S,2S,3R)-1-((.ALPHA.-D-GALACTOPYRANOSYLOXY)METHYL)-2,3-DIHYDROXYHEPTADECYL)-
- Hexacosanamide, N-(1-((alpha-D-galactopyranosyloxy)methyl)-2,3-dihdyroxyheptadecyl)-, (1S-(1R*,2R*,3S*))-
- hexacosanamide, N-[(1S,2S,3R)-1-[(alpha-D-galactopyranosyloxy)methyl]-2,3-dihydroxyheptadecyl]-
- Hexacosanamide, N-[(1S,2S,3R)-1-[(alpha-D-galactopyranosyloxy)methyl]-2,3-dihydroxyheptadecyl]- (9CI)
- Hexacosanamide, N-[1-[(alpha-D-galactopyranosyloxy)methyl]-2,3-dihydroxyheptadecyl]-, [1S-(1R*,2R*,3S*)]-
- N-((2S,3S,4R)-3,4-dihydroxy-1-((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl)oxyoctadecan-2-yl)hexacosanamide
- N-((2S,3S,4R)-3,4-dihydroxy-1-(3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)octadecan-2-yl)hexaicosanamide
- N-[(1S,2S,3R)-1-[(alpha-D-Galactopyranosyl)oxymethyl]-2,3-dihydroxyheptadecyl]hexacosanamide
- N-[(1S,2S,3R)-1-[(alpha-D-Galactopyranosyloxy)methyl]-2,3-dihydroxyheptadecyl]hexacosanamide
- N-[(1S,2S,3R)-2,3-dihydroxy-1-[[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxymethyl]heptadecyl]hexacosanamide
- N-[(2S,3S,4R)-3,4-dihydroxy-1-{[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}octadecan-2-yl]hexacosanamide
- N-{(1S,2S,3R)-1-[(alpha-D-galactopyranosyloxy)methyl]-2,3-dihydroxyheptadecyl}hexacosanamide